PhaseBio Pharmaceuticals, Inc. - COM Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2022

Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PhaseBio Pharmaceuticals, Inc. - COM across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q4 0 $0 -$6,000 0
2022 Q3 34,208 $6,000 $0.18 1
2022 Q2 34,208 $21,000 $0.61 1
2022 Q1 34,208 $45,000 $1.32 1
2021 Q4 34,208 $89,000 $2.60 1
2021 Q3 34,208 $106,000 $3.10 1
2021 Q2 34,208 $127,000 $3.71 1
2021 Q1 34,208 $118,000 $3.45 1
2020 Q4 34,208 $115,000 $3.36 1
2020 Q3 34,208 $120,000 $3.51 1
2020 Q2 34,208 $157,000 $4.59 1
2020 Q1 34,208 $113,000 $3.30 1
2019 Q4 34,208 $209,000 $6.11 1
2019 Q3 34,208 $143,000 $4.18 1
2019 Q2 34,208 $449,000 +$449,000 $13.13 1